Home›Stock Screener›Poly Medicure›Quarterly Results

Poly Medicure Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹92 Cr
QSept 2025
Quarterly Results

In Sept 2025, Poly Medicure (POLYMED) reported revenue ₹479 Cr and net profit ₹92 Cr — revenue +7.2% YoY. For annual financials, live price and key ratios, visit POLYMED company profile.

POLYMED Quarterly Results — Revenue, Profit & EPS Highlights

Poly Medicure latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View POLYMED 52-week chart for the annual high/low range and current price position.

  • Revenue of ₹479 Cr in Sept 2025 (+2.6% vs Mar 2025, +7.2% vs Sept 2024)
  • Net Profit of ₹92 Cr in Sept 2025 (+0.0% vs Mar 2025, +5.7% vs Sept 2024)
  • EBITDA of ₹150 Cr in Sept 2025 (+2.7% vs Mar 2025)
  • Operating Margin of 26.0% in Sept 2025 (-1.0pp vs Mar 2025)
  • Earnings Per Share of ₹9.06 in Sept 2025 (+1.6% vs Mar 2025)

Poly Medicure Quarterly Results — Revenue, EBITDA, Net Profit & EPS

POLYMED quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 479 467 447 522 447 2.6% 7.2%
Net Profit (₹ Cr) 92 92 93 71 87 - -
EBITDA (₹ Cr) 150 146 149 132 142 - -
EPS (₹) 9.06 8.92 9.19 7.00 9.01 - -
Operating Margin (%) 26.0% 27.0% 26.0% 21.0% 27.0% - -

POLYMED Share Price Trend — 1-Year Movement Across Quarterly Results

Poly Medicure 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices.

Profitability Ratios

Profit Margin 19.2%
EBITDA Margin 31.3%
Operating Margin 26.0%
ROE (Annual) 13.3%

Balance Sheet Highlights

Total Assets ₹3,193 Cr
Total Equity ₹2,766 Cr
Current Assets ₹1,917 Cr
Current Liabilities ₹57 Cr

Cash Flow Analysis

Operating Cash Flow ₹240 Cr
Investing Cash Flow ₹-1,194 Cr
Financing Cash Flow ₹951 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹1512.10
Exchange NSE
Last Updated Apr 30, 2026

Revenue Trend (₹ Cr)

Dec 2025 522
Jun 2025 447
Mar 2025 467
Sept 2025 479

Net Profit Trend (₹ Cr)

Dec 2025 71
Jun 2025 93
Mar 2025 92
Sept 2025 92

Operating Margin Trend (%)

Dec 2025 21.0%
Jun 2025 26.0%
Mar 2025 27.0%
Sept 2025 26.0%

POLYMED vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Poly Medicure latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹415,924.72 Cr 1808.3 14,875 3,125 +10.8% - 21.0% 139.1
Divis Laboratories
Sept 2025 		₹171,625.44 Cr 6502.5 2,860 689 +7.1% - 24.1% 250.4
Torrent Pharmaceuti…
Sept 2025 		₹142,059.09 Cr 4185.1 3,219 591 +11.3% - 18.4% 238.6
Dr Reddys Laborator…
Sept 2025 		₹110,348.15 Cr 1322.9 9,135 1,337 +1.1% - 14.6% 81.8
Cipla
Sept 2025 		₹105,996.98 Cr 1309.6 7,716 1,353 +12.0% - 17.5% 78.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores